XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.3
GENERAL - Identifiable net assets of Gesher (Details)
$ / shares in Units, $ in Thousands
 6 Months Ended
Jan. 25, 2023
USD ($)
shares
$ / shares
Jun. 30, 2023
USD ($)
Options
Jun. 30, 2024
shares
Disclosure of detailed information about biological assets [line items]      
Shares issued to Gesher shareholders   1,195,671 0
IFRS 2 Listing expenses (A+B-C) $ 46,717 $ 46,717  
Gesher      
Disclosure of detailed information about biological assets [line items]      
Shares issued to Gesher shareholders | shares 4,287,156    
Opening price of the Company's share on Nasdaq as of January 25, 2023 ($) | $ / shares $ 10.23    
(A) Fair value of the Company's shares issued to Gesher shareholders $ 43,858    
Opening price of the Company's warrants on Nasdaq as of January 25, 2023 ($) | $ / shares $ 0.74    
(B) Fair value of the Company's warrants issued to Gesher shareholders $ 9,012    
Gesher's cash in trust 8,127    
Gesher's liabilities (1,974)    
(C) Net assets of Gesher 6,153    
IFRS 2 Listing expenses (A+B-C) $ 46,717    
Gesher | Warrants liability      
Disclosure of detailed information about biological assets [line items]      
Shares issued to Gesher shareholders | shares 12,250,000